ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1845

Mortality Prognostic Factors of Critically Ill Patients with Systemic Autoimmune Diseases Admitted in a Medical Intensive Care Unit: A 20-year Cohort Study

Pamela Doti1, Ana Luisa Cunha2, Armin Quispe Cornejo3, Ángela Nieto González1, Andre Matos1, Pedro Guevara Hernández1, Pedro Castro Rebollo1 and Gerard Espinosa Garriga1, 1Hospital Clínic, Barcelona, Spain, 2Hospital Senhora da Oliveira, Guimarães, Porto, Portugal, 3Erasme Hospital, Brussels, Belgium

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, Cohort Study, Miscellaneous Rheumatic and Inflammatory Diseases, Mortality

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster III

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: To describe the clinical characteristics of a 20-year cohort of patients with systemic autoimmune diseases (SAD) admitted to a medical intensive care unit (ICU) and to identify mortality prognostic factors.

Methods: A single-center retrospective, observational study including all adult patients with SAD admitted to a medical ICU of a tertiary referral center between 1999 and 2019. Adults with a SAD diagnosis according to accepted criteria and made prior or during to ICU admission were included. Patients with ICU stay less than 48 hours and those with short-term irreversible disease were excluded. The reason for ICU admission, clinical follow-up, immunosuppressive treatment received before and during ICU admission, and outcome were collected. The association between the outcome (ICU death or survival) and predictors variables was measured by odds ratio using logistic regression models.

Results: One hundred patients accounting for 111 ICU admissions (34.2% male) with a mean age of 62 [40-74] years were included. Most patients had systemic lupus erythematosus (SLE) (29.5%) or systemic vasculitis (38.7%). Comorbidities were present in 60 (68.2%) patients at ICU admission being the chronic kidney disease (25.2%) the most frequent followed by interstitial lung disease (18.9%). Seventy-five (67.6%) patients were under immunosuppressive treatment before ICU admission. The reasons for ICU admission were infection in 41 (36.9%) patients followed by autoimmune disease flare-up in 30 (27%). Other complications related or not to the SAD were present in 32 (28.8%) patients. At admission, 73 (65.5%) patients had respiratory failure and 41 (56.2%) of them required mechanical ventilation. Fifty (45%) patients had acute kidney injury and 41 (36.3%) required vasoactive drugs due to hemodynamic instability at admission. The mean ICU length of stay (LOS) was 8 [IQR 4-18] days and hospital LOS was 26 [IQR 13.5-45] days. A total of 25 (22.1%) patients died in the ICU (40% male) being septic shock and respiratory failure the most frequent causes. Multivariable analysis demonstrated that chronic kidney disease (OR 3.5, 95%CI 1.1-11.0, [p=0.036]), corticosteroid treatment prior to ICU admission (OR 3.2, 95%CI 1.1-9.7, [p=0.04]), and the need of mechanical ventilation during ICU admission (OR 4.8, 95%CI 1.5-15.5, [p: 0.008]) were associated independently with ICU mortality after adjusting for age and sex.

Conclusion: The most prevalent SADs admitted to a medical ICU were SLE and systemic vasculitis being infection the main reason for admission. The presence of renal failure, corticosteroid treatment before ICU admission, and the need for mechanical ventilation during ICU stay were factors associated with increased risk of mortality.


Disclosures: P. Doti, None; A. Cunha, None; A. Quispe Cornejo, None; Á. Nieto González, None; A. Matos, None; P. Guevara Hernández, None; P. Castro Rebollo, None; G. Espinosa Garriga, None.

To cite this abstract in AMA style:

Doti P, Cunha A, Quispe Cornejo A, Nieto González Á, Matos A, Guevara Hernández P, Castro Rebollo P, Espinosa Garriga G. Mortality Prognostic Factors of Critically Ill Patients with Systemic Autoimmune Diseases Admitted in a Medical Intensive Care Unit: A 20-year Cohort Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/mortality-prognostic-factors-of-critically-ill-patients-with-systemic-autoimmune-diseases-admitted-in-a-medical-intensive-care-unit-a-20-year-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mortality-prognostic-factors-of-critically-ill-patients-with-systemic-autoimmune-diseases-admitted-in-a-medical-intensive-care-unit-a-20-year-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology